ZA939153B - Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development - Google Patents

Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development

Info

Publication number
ZA939153B
ZA939153B ZA939153A ZA939153A ZA939153B ZA 939153 B ZA939153 B ZA 939153B ZA 939153 A ZA939153 A ZA 939153A ZA 939153 A ZA939153 A ZA 939153A ZA 939153 B ZA939153 B ZA 939153B
Authority
ZA
South Africa
Prior art keywords
disease
development
parkinson
idazoxan
derivatives
Prior art date
Application number
ZA939153A
Other languages
English (en)
Inventor
Francis Colpaert
Mike Briley
Thierry Imbert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of ZA939153B publication Critical patent/ZA939153B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
ZA939153A 1992-12-07 1993-12-07 Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development ZA939153B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214694A FR2698789B1 (fr) 1992-12-07 1992-12-07 Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.

Publications (1)

Publication Number Publication Date
ZA939153B true ZA939153B (en) 1994-08-05

Family

ID=9436284

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939153A ZA939153B (en) 1992-12-07 1993-12-07 Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development

Country Status (10)

Country Link
EP (1) EP0671915B1 (xx)
JP (1) JPH08504203A (xx)
AT (1) ATE181503T1 (xx)
AU (1) AU687023B2 (xx)
CA (1) CA2151039A1 (xx)
DE (1) DE69325462D1 (xx)
FR (1) FR2698789B1 (xx)
NZ (1) NZ258591A (xx)
WO (1) WO1994013285A1 (xx)
ZA (1) ZA939153B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281207B1 (en) 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
FR2814368B1 (fr) * 2000-09-26 2004-05-07 Pf Medicament Preparation pharmaceutique a base d'oxans
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FR2861299B1 (fr) 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US7595335B2 (en) 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US8476307B2 (en) 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NZ258591A (en) 1997-06-24
EP0671915A1 (fr) 1995-09-20
AU687023B2 (en) 1998-02-19
AU5653094A (en) 1994-07-04
EP0671915B1 (fr) 1999-06-23
FR2698789B1 (fr) 1995-03-03
FR2698789A1 (fr) 1994-06-10
JPH08504203A (ja) 1996-05-07
ATE181503T1 (de) 1999-07-15
WO1994013285A1 (fr) 1994-06-23
DE69325462D1 (de) 1999-07-29
CA2151039A1 (fr) 1994-06-23

Similar Documents

Publication Publication Date Title
NO20093253L (no) Forbindelser, farmasoytiske formuleringer og anvendelse av forbindelsene til fremstilling av legemiddel
NL300209I2 (nl) Benzonaftaleenderivaten, werkwijze voor de bereiding ervan en hun toepassing op farmaceutisch en cosmetisch gebied.
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
MY113062A (en) Amide derivatives and their therapeutic use
ZA939153B (en) Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
MY102003A (en) Novel derivatives of 4, 5-dihydrooxazoles, a process for their preparation, and their use.
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
ATE169635T1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
MY103293A (en) N-imidazolyl derivatives of bicyclic compounds useful in medicine
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
MY133438A (en) Morpholinobenzamide salts
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
NO173278C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 5-androsten-17-on-derivater
HUP0003023A2 (hu) (S)-[2-Fenil-2-(metil-amino)-butil]-3,4,5-trimetoxi-benzoát és alkalmazása krónikus fájdalmak kezelésében
PL364794A1 (en) 2-aminotetralin derivatives for the therapy of glaucoma
GB8608893D0 (en) D-nor-7-ergoline derivatives
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
DK644487A (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
BR9812862A (pt) Composto, formulação farmacêutica, e, processo para a preparação de um composto
AU5893398A (en) Pharmaceutical composition for the treatment of so-called restless legs
GEP20012366B (en) Thienyl-, Furil-, Pyrrolyl- and Biphenyl-Sulfonamides, Their Derivatives, Their Use in Medicinal Purposes, Pharmaceutical Composition Containing the Same and Method for Treatment